Pharmaceutical industry braces itself for government changes to drug pricing
The new Government has indicated that drug pricing will be subject to value-based pricing through NICE, which may delay drug launches.
BMJ 2010; 340:c2933
The new Government has indicated that drug pricing will be subject to value-based pricing through NICE, which may delay drug launches.
BMJ 2010; 340:c2933
Powered by WordPress